Lipoproteins, Human Plasma, Intermediate Density recombinant protein
IDL
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q07954 |
---|---|
Calculated MW | 5.0-10,000.0 kDa |
Gene ID | 4035 |
---|---|
Gene Symbol | LRP1 |
Other Names | IDL |
Source | Human plasma |
Assay&Purity | SDS-PAGE; ≥95% |
Assay2&Purity2 | HPLC; ≥95% |
Recombinant | No |
Format | Liquid |
Storage | +4°C; Liquid in 150 mM NaCl, pH 7.4, and 0.01% EDTA |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
IDL functions in the endogenous lipid transport system. It is the particle resulting from the interaction of VLDL and lipoprotein lipase. When IDL receives cholesteryl esters from HDL, it is converted to cholesteryl ester-rich LDL.
References
Herz J.,et al.EMBO J. 7:4119-4127(1988).
Van Leuven F.,et al.Genomics 24:78-89(1994).
Van Leuven F.,et al.Genomics 52:138-144(1998).
Scherer S.E.,et al.Nature 440:346-351(2006).
Kutt H.,et al.Biochim. Biophys. Acta 1009:229-236(1989).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.